Securing this treatment can be a challenge for many. Currently, it is limited and demands a prescription from a doctor . Receiving retatrutide typically involves participating in a clinical trial , though future expanded availability through traditional healthcare systems is being explored – though a timeframe for this remains undefined . Patient